ID   ODY1
AC   CVCL_C1JC
SY   ODY
DR   Wikidata; Q114312628
RX   PubMed=2998993;
RX   PubMed=4333769;
RX   PubMed=7316467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=4333769; DOI=10.1093/jnci/48.3.623;
RA   Steel, Christopher Michael
RT   "Human lymphoblastoid cell lines. III. Co-cultivation technique for
RT   establishment of new lines.";
RL   J. Natl. Cancer Inst. 48:623-628(1972).
//
RX   PubMed=2998993;
RA   Steel, Christopher Michael
RA   Morten, John E.N.
RA   Foster, Michael E.
RT   "The cytogenetics of human B lymphoid malignancy: studies in Burkitt's
RT   lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell
RT   lines.";
RL   IARC Sci. Publ. 60:265-292(1985).
//
RX   PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x;
RA   Povey, Susan
RA   Jeremiah, Stephen
RA   Arthur, Elizabeth
RA   Steel, C. Michael
RA   Klein, George
RT   "Differences in genetic stability between human cell lines from
RT   patients with and without lymphoreticular malignancy.";
RL   Ann. Hum. Genet. 44:119-133(1980).
//